Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 760
Sarcoma treatment in the era of molecular medicine
Thomas G. P. Grünewald, Marta M. Alonso, Sofia Avnet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 241
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
Crescenzo D’Alterio, Stefania Scala, Gabriella Sozzi, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 351-361
Open Access | Times Cited: 182
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Maria Laura De Angelis, Federica Francescangeli, Ann Zeuner
Cancers (2019) Vol. 11, Iss. 10, pp. 1569-1569
Open Access | Times Cited: 149
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 115
Drug-Tolerant Persister Cells in Cancer Therapy Resistance
Pavan Kumar Dhanyamraju, Todd D. Schell, Shantu Amin, et al.
Cancer Research (2022) Vol. 82, Iss. 14, pp. 2503-2514
Open Access | Times Cited: 72
Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling
Cong Li, Shi Qiu, Xiaohan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 57
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, et al.
Cancer and Metastasis Reviews (2023)
Open Access | Times Cited: 42
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy
Ryungsa Kim, Takanori Kin, William T. Beck
Cancers (2024) Vol. 16, Iss. 5, pp. 984-984
Open Access | Times Cited: 21
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Yixiang Gu, Ruifeng Yang, Yang Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
Ritama Paul, Jay F. Dorsey, Yi Fan
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107985-107985
Open Access | Times Cited: 101
When dormancy fuels tumour relapse
Karla Santos-de-Frutos, Nabil Djouder
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 92
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 87
Role of Mitochondria in Cancer Stem Cell Resistance
José Manuel García-Heredia, Amancio Carnero
Cells (2020) Vol. 9, Iss. 7, pp. 1693-1693
Open Access | Times Cited: 79
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 70
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology (2021) Vol. 86, pp. 769-781
Open Access | Times Cited: 68
3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
Elisa Suárez-Martínez, Irene Suazo-Sanchez, Manuel Celis-Romero, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 58
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5167-5167
Open Access | Times Cited: 44
Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment
Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer
Yosui Nojima, Ryoji Yao, Takashi Suzuki
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167693-167693
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top